2-21015452-C-T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_000384.3(APOB):​c.3426G>A​(p.Ser1142Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00141 in 1,614,016 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0019 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0014 ( 13 hom. )

Consequence

APOB
NM_000384.3 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:11

Conservation

PhyloP100: -0.250

Publications

5 publications found
Variant links:
Genes affected
APOB (HGNC:603): (apolipoprotein B) This gene product is the main apolipoprotein of chylomicrons and low density lipoproteins (LDL), and is the ligand for the LDL receptor. It occurs in plasma as two main isoforms, apoB-48 and apoB-100: the former is synthesized exclusively in the gut and the latter in the liver. The intestinal and the hepatic forms of apoB are encoded by a single gene from a single, very long mRNA. The two isoforms share a common N-terminal sequence. The shorter apoB-48 protein is produced after RNA editing of the apoB-100 transcript at residue 2180 (CAA->UAA), resulting in the creation of a stop codon, and early translation termination. Mutations in this gene or its regulatory region cause hypobetalipoproteinemia, normotriglyceridemic hypobetalipoproteinemia, and hypercholesterolemia due to ligand-defective apoB, diseases affecting plasma cholesterol and apoB levels. [provided by RefSeq, Dec 2019]
APOB Gene-Disease associations (from GenCC):
  • hypercholesterolemia, autosomal dominant, type B
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • familial hypobetalipoproteinemia 1
    Inheritance: AR, SD, AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Genomics England PanelApp
  • homozygous familial hypercholesterolemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 2-21015452-C-T is Benign according to our data. Variant chr2-21015452-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 334155.
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.00136 (1993/1461886) while in subpopulation MID AF = 0.0224 (129/5768). AF 95% confidence interval is 0.0192. There are 13 homozygotes in GnomAdExome4. There are 1054 alleles in the male GnomAdExome4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 13 AD,AR,SD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000384.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
APOB
NM_000384.3
MANE Select
c.3426G>Ap.Ser1142Ser
synonymous
Exon 22 of 29NP_000375.3P04114

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
APOB
ENST00000233242.5
TSL:1 MANE Select
c.3426G>Ap.Ser1142Ser
synonymous
Exon 22 of 29ENSP00000233242.1P04114
APOB
ENST00000673739.2
n.*2732G>A
non_coding_transcript_exon
Exon 21 of 25ENSP00000501110.2A0A669KB70
APOB
ENST00000673882.2
n.*2521G>A
non_coding_transcript_exon
Exon 20 of 23ENSP00000501253.2A0A669KB70

Frequencies

GnomAD3 genomes
AF:
0.00187
AC:
285
AN:
152012
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000653
Gnomad AMI
AF:
0.00548
Gnomad AMR
AF:
0.00367
Gnomad ASJ
AF:
0.0259
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00166
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00123
Gnomad OTH
AF:
0.00525
GnomAD2 exomes
AF:
0.00215
AC:
541
AN:
251448
AF XY:
0.00226
show subpopulations
Gnomad AFR exome
AF:
0.000492
Gnomad AMR exome
AF:
0.00217
Gnomad ASJ exome
AF:
0.0226
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.00129
Gnomad OTH exome
AF:
0.00554
GnomAD4 exome
AF:
0.00136
AC:
1993
AN:
1461886
Hom.:
13
Cov.:
33
AF XY:
0.00145
AC XY:
1054
AN XY:
727246
show subpopulations
African (AFR)
AF:
0.00167
AC:
56
AN:
33480
American (AMR)
AF:
0.00217
AC:
97
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0239
AC:
625
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.00159
AC:
137
AN:
86258
European-Finnish (FIN)
AF:
0.0000936
AC:
5
AN:
53418
Middle Eastern (MID)
AF:
0.0224
AC:
129
AN:
5768
European-Non Finnish (NFE)
AF:
0.000658
AC:
732
AN:
1112006
Other (OTH)
AF:
0.00349
AC:
211
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
141
282
422
563
704
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00187
AC:
284
AN:
152130
Hom.:
1
Cov.:
32
AF XY:
0.00182
AC XY:
135
AN XY:
74370
show subpopulations
African (AFR)
AF:
0.000651
AC:
27
AN:
41494
American (AMR)
AF:
0.00366
AC:
56
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.0259
AC:
90
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5168
South Asian (SAS)
AF:
0.00187
AC:
9
AN:
4812
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10574
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.00122
AC:
83
AN:
68008
Other (OTH)
AF:
0.00520
AC:
11
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.517
Heterozygous variant carriers
0
14
28
43
57
71
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00228
Hom.:
0
Bravo
AF:
0.00178
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not provided (5)
-
-
2
Familial hypercholesterolemia (2)
-
-
1
Cardiovascular phenotype (1)
-
1
-
Familial hypobetalipoproteinemia 1 (1)
-
1
-
Hypercholesterolemia, autosomal dominant, type B (1)
-
-
1
Hypercholesterolemia, autosomal dominant, type B;C4551990:Familial hypobetalipoproteinemia 1 (1)
-
-
1
Hypercholesterolemia, familial, 1 (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
2.3
DANN
Benign
0.73
PhyloP100
-0.25
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142448733; hg19: chr2-21238324; COSMIC: COSV51948770; API